Lu Ke

Institution
Chinese Academy of Sciences

Country
China

Field
Materials Sciences

Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.

(Photo: Future Science Prize)

AWARDS
  • Future Science Prize 2020

Related articles

China Outpaces India For Women In The Workforce

One in six college-educated Indian women works full time for an employer, says Steve Crabtree and Anita Pugliese, based on data from a new Gallup poll.

Soldier Beetles Synthesize Fatty Acids For Defense

Scientists have discovered the three genes that combine to provide soldier beetles with their potent predator defense system.

Quality Education Still A Long Way Off In Pakistan

Despite making education a constitutional right in 2010, Pakistan is unlikely to fulfill its Millennium Development Goal of achieving universal education by 2015.

1000 Genomes Project Helps Advance Personalized Medicine

By decoding the genomes of more than 1,000 people from Han Chinese in Beijing to Japanese in Tokyo, scientists have compiled the largest and most detailed catalog yet of human genetic variation.

Mainstreaming Science In South Asia

Educating children and women is essential to mainstreaming science in South Asia, writes T. V. Padma.

Koshik The ‘Korean’ Elephant Can Say Annyong, Anja, Aniya, Nuo, And Choah

An Asian elephant named Koshik can imitate human speech, speaking a grand total of five words in Korean by vocalizing with his trunk in his mouth.

Indonesia’s Plans To Cut Science Classes Raise Protests

Despite protests by parents, educators, and education observers, the Indonesian government is still moving forward to eliminate science classes from elementary schools.

Novartis To Build US$500m Biotech Facility In Singapore

Novartis announced today the construction of a new state-of-the-art biotechnology facility in Singapore with an investment valued at over US$500 million.

Del Mar Pharma Announces Strategic Collaboration In China

Del Mar Pharma announced on Monday a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083, known in China as DAG for Injection.